| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 8.97M | — |
| Operating expense | — | — |
| Net income | -43.40M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GLUE returned +196.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -8.8% |
| 1 year | +196.7% |
| 5 years | -59.9% |
| All-time high | $35.69 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in GLUE would be worth today ›No. Monte Rosa Therapeutics, Inc. has not paid a dividend in the past 12 months.
Monte Rosa Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol GLUE.
Monte Rosa Therapeutics, Inc. is part of the Healthcare sector.
Monte Rosa Therapeutics, Inc. has a market cap of 1.22B USD, based on the latest quote.
Monte Rosa Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
